NHI Announces Fourth Quarter 2021 Earnings Release and Conference Call Date

3 years ago

MURFREESBORO, TN / ACCESSWIRE / February 3, 2022 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of…

CORRECTION: Goodbody Health Announces OTC Ticker Change

3 years ago

This press release replaces the press release disseminated February 3, 2022 at 7:01 AM ET. The press release contained incomplete…

Advanced Proteome Therapeutics Update on Plans for 2022

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company"), is…

Lobe Sciences Ltd. Acquires Securities of Ionic Brands Corp.

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2022) - Lobe Sciences Ltd. (the "Acquiror") announces, pursuant to the early warning…

Psychedelics Company Silo Wellness Announces USD$495,000 Strategic Equity Investment by Socially Conscious Metaverse and Psychedelics Holding Company Orthogonal Thinker

3 years ago

Toronto, Ontario--(Newsfile Corp. - February 3, 2022) - Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K70) ("Silo Wellness" or…

Save On Foods Increases First Order of Boosh from 120 to 170 Stores

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh"…

Cloud DX Reveals EXtended Reality (“XR”) Division to Bring to Market Award-Winning, Patented Metaverse Application

3 years ago

Cloud XR's Virtual Clinician Assistant™ offers healthcare teams an immersive and real-time augmented clinical experience, ripe for the evolving Medical…

Emergent Health to Enter the Projected $60 Billion Global Anti-Aging Market

3 years ago

KING OF PRUSSIA, PA / ACCESSWIRE / February 3, 2022 / Emergent Health Corp., (OTC PINK:EMGE) announces entering the projected…

Gemina Labs Announces Completion of Significant Development Step for its SARS-CoV-2 Rapid Test

3 years ago

VANCOUVER, BC / ACCESSWIRE / February 3, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to…

Novamind Hosts Clinical Trial to Advance Ketamine Therapy for End-of-Life Patients

3 years ago

TORONTO, ON / ACCESSWIRE / February 3, 2022 / Novamind Inc. (CSE:NM | OTCQB:NVMDF | FSE:HN2) ("Novamind" or the "Company"),…